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Introduction
The spindle assembly checkpoint (SAC) ensures faithful separation of mitotic sister chromatids by monitoring interactions between kinetochores (KTs) and microtubules (MTs) (reviewed in [1] [2] [3] ). The SAC controls the anaphase promoting complex/ cyclosome (APC/C), a ubiquitin ligase that is crucial for mitotic exit. SAC activation causes sequestration of an APC/C activator, Cdc20, within an inhibitory complex called the mitotic checkpoint complex (MCC). The MCC is composed of Cdc20 and SAC proteins Mad2, BubR1, Bub3. The Mad2 protein exists in 2 states, the inactive open state (o-Mad2) and the active closed state (c-Mad2); c-Mad2 is incorporated into the MCC complex. Conversion of o-Mad2 to c-Mad2 occurs at a "catalytic platform" complex on unattached KTs, comprised of c-Mad2 and Mad1.
Mad1 and Mad2 are not essential in budding yeast unless KT MTs are disrupted, 4 suggesting that the SAC is not required for spindle structure or chromosome segregation per se. However, Mad1 and Mad2 are essential for correct chromosome segregation and organismal viability in metazoans, 5, 6 indicating that the SAC is required in higher eukaryotes even without external perturbation of spindle assembly. This difference reflects the fact that yeast KTs are constitutively MT bound throughout the cell cycle, whereas organisms that undergo open mitosis re-establish KT-MT attachments after nuclear envelope breakdown (NEBD) in each cell division. Unattached KTs transiently invoke the SAC during the interval between NEBD and MT attachment, and subsequent SAC silencing helps to determine the timing of anaphase onset. 6 SAC silencing is not fully understood, although it clearly involves a number of crucial events, including both inactivation of the catalytic platform at KTs and disassembly of existing MCC.
1 p31 comet is a protein found in higher eukaryotes that plays an important role in SAC silencing. 7 p31 comet over-expression in tissue culture cells overrides the SAC, while p31 comet knockdown delays anaphase onset. 8, 9 p31 comet is structurally related to Mad2 10 and it binds c-Mad2 in a manner that is essential for its role in SAC silencing. 8, 11 Two mechanisms have been suggested for p31 comet activity: First, p31 comet has been proposed to disrupt soluble MCC. This model is supported by the capacity of p31 comet to bind c-Mad2 within the MCC in vitro and thereby disrupt that complex. 12 Second, p31 comet associates with unattached KTs through direct binding to c-Mad2. 8, 11 p31 comet binding to c-Mad2 occludes o-Mad2 binding, 10 and a "capping" model has been proposed wherein p31 comet blocks MCC generation by inhibition of the Mad1/c-Mad2 catalytic platform. checkpoints, including the SAC. For example, the SAC becomes activated by unattached KTs in CSF-XEEs containing DSN and the MT-depolymerizing agent nocodazole, preventing anaphase onset even after CaCl 2 addition and CSF degradation. Cycling XEE are produced through an alternative protocol, so that they mimic the cell cycle of the fertilized egg, spontaneously alternating between interphase and mitosis.
14 Like CSF-XEE, cycling XEE activate the SAC in response to unattached KTs. Purified p31 comet antagonizes Mad2 inhibition of APC/C cdc20 in XEE. 15 We have used XEEs for investigation of the mitotic role(s) and regulation of p31 comet . Here we show that p31 comet depletion from XEE caused a SAC-dependent delay in anaphase onset, suggesting that endogenous p31 comet is important for mitotic timing in this system. p31 comet was mitotically phosphorylated in XEE. While a number of well-established mitotic kinases did not efficiently modify p31 comet in vitro, IKK-b (Inhibitor of nuclear factor k-B kinase-b) was effective for p31 comet phosphorylation. Depletion or inhibition of IKK-b delayed mitotic exit of XEEs, and a phosphomimetic p31 comet mutant showed increased activity in dissociation of soluble MCC and particularly in disruption of KT association of SAC components. Together, our results suggest that p31 comet contributes to the timing of anaphase onset in XEE through antagonism of the SAC and that IKK-b modifies p31 comet to enhance its activity.
Results
Xenopus p31 comet promotes SAC silencing in XEE To test whether p31 comet modulates mitotic exit timing in XEE under circumstances permissive for spindle assembly, we incubated control and p31 comet -depleted CSF-XEE reactions containing DSN for 15 min. at 23 C, followed by CaCl 2 addition to initiate mitotic exit. We examined the progression of each reaction into interphase through Western blotting for Cyclin B. Cyclin B degradation was significantly slower in p31 cometdepleted samples (Fig. 1A) in a manner that could be rescued by addition of recombinant p31 comet . These observations indicate that p31 comet facilitates mitotic exit in CSF-XEE containing DSN.
We postulated that transiently unattached KTs temporarily activate the SAC in XEEs, and that p31 comet promotes subsequent SAC silencing after MT-KT attachments were formed. To test this idea, we examined whether the delay in p31 cometdepleted XEEs requires Mad2 (Fig. 1B, C) . Mad2 depletion alone accelerated the rate of Cyclin B degradation, consistent with the notion that SAC activation modulates mitotic exit timing. The presence or absence of p31 comet did not significantly alter Cyclin B degradation in Mad2-depleted XEEs, indicating that p31 comet modulates mitotic exit through Mad2. Spindle morphology and MT density were indistinguishable in the presence and absence of p31 comet (Fig. S1A) , arguing that p31 comet depletion did not delay mitotic exit by disrupting spindle assembly, and p31 comet -depleted XEEs could activate their SAC in response to fully unattached KTs. (Fig. S1B) .
Together, these observations suggest that the SAC slows mitotic exit in CSF-XEE containing DSN, and that p31 comet promotes anaphase by antagonizing the SAC. This observation is consistent with reports that p31 comet -depleted HeLa cells show mitotic exit delays because they are unable to mediate SAC silencing. 8, 11, 16 p31 comet phosphorylation by IKK-b during mitotic exit It has been reported that mammalian p31 comet is phosphorylated during mitosis, 17, 18 and that phosphorylation of human p31 comet on Serine-102 weakens its interaction with Mad2 and its capacity to silence the SAC. 19 We wished to determine whether p31 comet might be phosphorylated in XEE, and, if so, what role this modification might play in its activity. To address this question, we took samples from a cycling XEE reaction at different times, and examined the activity of kinases that can phosphorylate p31 comet by adding GST-p31 comet and [g¡ 32 P] ATP to each sample. After 30 min., we re-isolated GST-p31 comet and subjected it to SDS-PAGE and autoradiography ( Fig. 2A) . We observed that kinase activity directed against GST-p31 comet increased progressively, peaking near the onset of Cyclin B degradation and mitotic exit in the intact cycling XEE (60 min.) and declining abruptly as the cycling XEE returned to interphase.
To determine which kinase mediates p31 comet phosphorylation, we examined the capacity of purified Mps1, Aurora B, Cyclin B/Cdk1 and IKK-b to phosphorylate GST-p31 ( Fig. 2B, Fig. S2 ). Mps1, Aurora B and Cyclin B/Cdk1 are wellstudied mitotic kinases. IKK-b has been implicated in spindle assembly 20 and SAC regulation. 21 The only kinase that efficiently phosphorylated GST-p31 comet in vitro was IKK-b. To test whether IKK-b has a major role in p31 comet phosphorylation, we performed kinase assays using CSF-XEE treated with IKK-b inhibitor TPCA ([5-(p-fluorophenyl)-2-ureido] thiophene-3-carboxamide). 22 TPCA both inhibited phosphorylation of GSTp31 comet in CSF-XEE (Fig. 2C ) and abolished IKK-b kinase activity toward GST-p31 comet reactions containing purified proteins (Fig. S3A) . TPCA did not inhibit phosphorylation of the Cyclin B/Cdk1 substrate Histone H1 within CSF-XEE (Fig. 2C) , arguing that it specifically blocked mitotic p31 comet phosphorylation through IKK-b inhibition.
We performed mass spectrometry to identify the sites on p31 comet phosphorylated by IKK-b in vitro, and identified Serine-4 (S4), Threonine-6 (T6) and Threonine-179 (T179) of p31 comet as candidate IKK-b sites (Fig. S4A) . Mutation of either S4 and T6 to alanine or S179 to alanine reduced in vitro p31 comet phosphorylation, while mutation of all 3 residues to alanines nearly abolished p31 comet modification (Fig. S4B) . We raised rabbit antibodies that specifically recognized p31 comet phosphorylated on S4 and T6 (p31
p antibodies did not recognize bacterially expressed GST-p31 comet on Western blots, but showed a prominent band of the appropriate molecular weight after GST-p31 comet was treated with IKK-b (Fig. S3B) . The appearance of this band was suppressed by the addition of TPCA to the reaction. In a similar fashion, the anti-p31
p antibodies recognized GST-p31 comet that had been incubated in XEE alone or in XEE plus DMSO, but not GST-p31 comet incubated in XEE reactions containing TPCA (Fig. S3C) . We also raised rabbit antibodies against Xenopus IKK-b (anti-xIKK-b), which were used to immunodeplete IKK-b from XEE. We examined the capacity of these depleted XEE to phosphorylate GST-p31 comet by Western blotting with anti-p31 comet -S4 p ,T6 p antibodies (Fig. S3D) . We observed that phosphorylation of p31 comet was abolished after IKKb depletion, but could be restored through the addition of purified human IKK-b at a similar concentration. These experiments collectively suggest that IKK-b phosphorylates p31 comet on S4 and T6, and that its kinase activity is essential for the modification of these residues in CSF-XEE.
In a manner similar to the experiment in Fig. 2A , we analyzed kinase activity against S4 and T6 of p31 comet in cycling XEE by Western blotting with anti-p31 comet -S4 p ,T6 p antibodies (Fig. 2D) . We observed that kinase activity against these residues peaked in mitosis, near the onset of Cyclin B degradation. TPCA abolished this peak of kinase activity toward p31 comet -S4 p ,T6 p ( Fig. S3E) . Interestingly, the peak of anti-p31 comet -S4 p ,T6 p kinase activity was somewhat sharper than overall kinase activity against p31 comet (compare Fig. 2A and D), potentially suggesting that p31 comet may be phosphorylated by other kinases during mitosis in addition to IKK-b. Our observations collectively indicate that p31 comet becomes phosphorylated near the onset of anaphase in XEE. Our data implicate IKK-b as a major kinase for at least a subset of these modifications, particularly S4 and T6.
Phosphomimetic p31
comet antagonizes the SAC To examine whether p31 comet phosphorylation changes its activity, we depleted endogenous p31 comet from CSF-XEE, followed by addition of physiological levels (15 nM) of recombinant wild type p31 comet (p31 comet-wt ), a phosphomimetic form of p31 comet , in which S4, T6 and T179 were mutated to glutamic acid (p31 comet-EEE ), or a non-phosphoryated form, in which those residues were mutated to alanine (p31 comet-AAA ). We added DSN to each reaction and incubated them at 23 C. After 15 min., we added CaCl 2 and took periodic samples for Western blotting analysis of Cyclin B levels (Fig. 3A) . p31 comet depletion delayed mitotic exit in a manner that was reversed by GSTp31 comet-wt , but not by GST. GST-p31 comet-AAA was less effective than comet-wt at relieving this mitotic delay, while GSTp31 comet-EEE was more effective in accelerating Cyclin B degradation. Collectively, these findings are consistent with the idea that p31 comet phosphorylation enhances its capacity to promote mitotic exit.
To test the role of p31 comet phosphorylation in controlling its antagonism of the SAC per se, 75 nM p31 comet-wt , p31
comet-AAA and p31 comet-EEE were added to p31 comet -depleted CSF-XEE that also contained DSN and nocodazole. The reactions were incubated for 30 min. to allow SAC activation. CaCl 2 was then added to cause CSF degradation, and mitotic exit was monitored by Western blotting with antibodies against Cyclin B (Fig. 3B) . As expected, a control sample to which DMSO had been added in place of nocodazole exited from mitosis within 30 min. of CaCl 2 addition. Cyclin B remained stable in a nocodazoletreated sample to which GST had been added, indicating the establishment of SAC arrest. 10 Mad2 L12A was immunoprecipitated from each reaction, and the bead-associated fractions were subjected to SDS-PAGE and Coomassie brilliant blue (CBB) staining (Fig. 4A) . While the levels of p31 comet-wt and p31 comet-AAA precipitated were similar, p31
comet-EEE was more abundant, suggesting that it bound to Mad2 L12A more tightly. We compared the capacity of recombinant p31 comet-wt , p31
comet-AAA and p31 comet-EEE to release Mad2 from Cdc20 when added to CSF-XEE containing DSN and nocodazole. In each case, p31
comet was added at increasing concentrations and incubated for 30 min. at 23 C. Cdc20 was then immunoprecipitated from each sample, co-precipitating Mad2 was detected by immunoblotting (Fig. 4B) . While all 3 forms of p31 comet disrupted the association of Cdc20 with Mad2, p31
comet-EEE was www.tandfonline.comnoticeably more effective. When we examined the capacity of p31 comet variants to release Mad2 from isolated MCC complexes (Fig. S5A) , p31 comet-EEE was similarly more efficient than p31 comet-wt or p31 comet-AAA . Together, these results suggest that p31 comet phosphorylation by IKK-b enhances its capacity for MCC dissociation, thus improving its capacity for SAC silencing.
To determine if IKK-b phosphorylation controls p31 comet activity at unattached KTs, we isolated chromatin from XEE incubated with nocodazole and p31 comet-wt , p31 comet-AAA and p31 comet-EEE . We analyzed the levels of KT-bound SAC components (Mad2, BubR1, Bub1), KT structural components (Spc24) and chromosome-associated inner centromeric proteins (Shugoshin1 and Aurora B).
23 p31 comet-wt and p31 comet-AAA had little effect on the chromosome-bound levels of these components (Fig. 4C, Fig. S5B ). By contrast, chromosomes showed a progressive loss of MCC components (Mad2, BubR1) and non-MCC SAC proteins (Bub1) with increasing p31 comet-EEE concentrations (Fig. 4C, Fig. S5B ). p31 comet-EEE was not effective in releasing SAC components from KT in Mad2-depleted XEEs (Fig. S5C) , consistent with the idea that p31 comet-EEE must associate with KT 8, 11 in order to act in this context. These data suggest Mad2-dependent p31 comet recruitment to KT allows it to play a positive role in dispersion of SAC proteins from KT, and that this function is enhanced by IKK-b phosphorylation. We did not observe appreciably higher levels of SAC proteins on KTs in p31 comet -depleted XEEs than in control samples, so we do not believe that p31 comet normally determines the maximal amount of their recruitment.
Depletion or inhibition of IKK-b compromises SAC silencing
Our findings indicated that p31 comet plays an important role in anaphase onset in XEE, and that its activity is significantly enhanced through phosphorylation by IKK-b. Together, these observations predicted that IKK-b should promote anaphase in XEE. To directly test this prediction, we examined the consequences of IKK-b inhibition or depletion upon mitotic exit in CSF-XEE. First, we added TPCA to CSF-XEE containing DSN. After 20 min. at 23 C, we added CaCl 2 and followed mitotic exit (Fig. 5A) . We observed slower Cyclin B degradation in the TPCA-treated reaction, indicating that IKK-b inhibition delays mitotic exit. Second, we examined mitotic exit in IKK-b-depleted CSF-XEE containing DSN. Spindles appeared normal in the absence of IKK-b before CaCl 2 addition (Fig. S6B) . However, mitotic exit was significantly delayed after CaCl 2 addition, with longer persistence of both high Cyclin B levels ( Fig. 5B ) and spindle MTs (Fig. S6B) . This delay was reversed through the addition of purified human IKK-b (Fig. S6A) . As with the delay caused by p31 comet depletion ( Figure 1B, C) , co-depletion of Mad2 restored anaphase progression in IKK-b-depleted XEEs (Fig. 5B) , consistent with the idea that IKK-b accelerates mitotic exit by antagonizing the SAC through p31 comet phosphorylation.
Discussion
SAC activation has been shown to occur transiently during each cell cycle in other metazoan systems, 5, 6 even in the absence of external perturbations, so that subsequent SAC silencing is pivotal in determining the timing of anaphase. Our data indicate that similar regulation can be recapitulated within the XEE in vitro system (Fig. 1) : Under the conditions that we have used, Mad2 depletion accelerated Cyclin B degradation in XEE, indicating that the SAC acts as a brake to anaphase progression. Moreover, p31 comet , a protein required for SAC silencing, promoted anaphase in this system. Since the presence or absence of p31 comet did not modulate anaphase timing in the absence of Mad2, our data suggest that p31 comet acts primarily by antagonizing the SAC. Furthermore, we found that kinase activity directed against p31 comet increased near anaphase onset in XEE, and that IKK-b was among the principal kinases that modify p31 comet in this interval (Fig. 2) . Analysis of phosphomimetic p31 comet mutants showed that p31 comet phosphorylation promotes its activity in SAC silencing (Figs. 3, 4) , while the depletion or inhibition of IKK-b reduced p31 comet 's capacity to act in this context (Fig. 5) . comet has been reported to act both on soluble MCC 11 and at KTs, 10,13 and we find evidence consistent with both modes of action in XEE (Fig. 4, Fig. S5) . Notably, while p31 comet-EEE was somewhat more efficient than p31
comet-wt at mediating the dissociation of Mad2 from Cdc20 within the soluble faction (Fig. 4B) , its release of SAC proteins from unattached KTs was dramatically better than p31 comet-wt (Fig. 4C) , suggesting that p31 comet phosphorylation by IKK-b particularly enhances its capacity to act at KT. We estimate that the concentration of p31 comet (15 nM) is much lower than the concentration of Mad2 (300 nM) within XEE (Fig. S7) . Because of this difference, endogenous p31 comet may only be sufficient to neutralize a small fraction of the soluble Mad2 through stoichiometric binding. 13 It is interesting to speculate that p31 comet phosphorylation may promote its activity specifically against the smaller pool of Mad2 associated to KT, and that this might be its primary site of action within XEE. Our findings are interesting in light of the underappreciated role of IKK-b within mitosis, which is distinct from its function in cellular stress and inflammatory signaling pathways. 24 IKK-b depletion causes mitotic delays in mammalian cells, accompanied by spindle assembly defects and stabilization of the Aurora A kinase. 20 On the other hand, the IKK-b inhibitor BMS-345541 causes precocious APC/C activation in tissue culture cells, resulting in early mitotic exit, defective chromosome separation and improper cytokinesis, and BMS-345541 can override the SAC in nocodazole-arrested cells. 21 It is notable in this context that the transcription factor NF-kB, a critical IKK-b target, controls the expression of numerous cell cycle regulators. 24 NF-kB's activity is stimulated by drugs that act on the MT cytoskeleton, including taxol or nocodazole, 25, 26 suggesting the interesting possibility that the SAC may regulate IKK-b.
It is not clear why IKK-b depletion 20 and its chemical inhibition 21 have opposite effects on mitotic exit in mammalian cells, with the former causing mitotic arrest while the latter promotes SAC release. These distinct phenotypes may reflect the activity of IKK-b against multiple downstream targets. Within XEEs, a simpler system that does not require gene expression, 14 IKK-b depletion and its inhibition by TPCA both caused mitotic exit delays (Fig. 5) . It seems likely that p31 comet phosphorylation by IKK-b contributes to its capacity to promote mitotic exit in XEE, since phosphomimetic p31 comet-EEE was more effective than wild type p31 comet in a variety of assays for Mad2 binding and SAC release (Figs. 3, 4) . Since structural analysis of the complex between Mad2 with p31 comet did not resolve the first 53 residues within p31 comet 's N-terminal domain, 10 it is difficult to speculate mechanistically as to how phosphorylation of this region might enhance the stability of Mad2-p31 comet association. The N-terminus of Xenopus p31 comet is not closely conserved with mammalian p31 comet homologues (Fig. S8) . Nevertheless, alignment of their sequences shows that mouse p31 comet has residues that may correspond to the S4 and T6 phosphorylation sites, while human p31 comet shares the site corresponding to T6. This relationship suggests that p31 comet phosphorylation by IKK-b could be important for mitotic control in mammals as well as amphibians, a possibility that we are currently testing.
In summary, our results show that the SAC can modulate anaphase timing in XEE without external perturbation of spindle assembly, and suggest a model in which IKK-b enhances mitotic exit in XEE at least partially through phosphorylation and activation of p31 comet as a SAC release factor. While previous reports have indicated a role of IKK-b within mitosis, our findings are among the first mechanistic insights into the nature of this role. These observations point toward an interesting possible convergence of two disparate fields through the action of a classical signaling kinase upon the mitotic machinery.
Materials and Methods

Constructs and protein purification
We performed a blast search using the human p31 comet protein sequence against the X. laevis and X. tropicalis mRNA plus EST cluster database (protein query to DNA database) to identify the Xenopus homolog of p31 comet . The cDNA sequence that we retrieved (Genbank: CA973841.1) encodes a protein that is 52% identical and 64% similar to the human p31 comet protein (Fig.  S8) .
A cDNA encoding wild type Xenopus p31 comet was amplified from a X. laevis cDNA library using forward (ATGGCGCA-GAGTGGCACAGATCTACC) and reverse (TCAGTTGT-GAAACCCCTTTACTAT) primers. It was subcloned into a pGEX4T1 vector for protein expression in E. Coli, or into pFastBac HT for expression in Baculovirus infected insect cells. p31 comet phosphomimetic and phosphodeficient mutants were generated using PCR-based site-directed mutagenesis. Xenopus Mad2 was cloned into pGEX4T1 using forward (ATGTCGTC-CATCTTGCCTTTCACCCCGCCAGTAG) and reverse (TTAGGACATGCTTGAGCAGCGGACTGAAGGG-GATCCCATCTGTGT) primers. Xenopus Mad2L12A was generated by site direct mutagenesis.
GST-tagged p31 comet variants and Mad2 were purified from E. Coli using glutathione Sepharose beads (Amersham). The GST tag of GST-Mad2L12A was subsequently removed by thrombin digestion. His 6 -tagged p31 comet variants were purified from Baculovirus infected insect cell lysates using Ni 2C -NTA resin (Qiagen).
Antibodies, Western blotting and kinases
Rabbit anti-Xenopus p31 comet , anti-Xenopus Mad2 and antiXenopus IKK-b were raised by Pacific Immunology Corporation (Ramona, CA) against p31 comet (full length), Mad2 (full length) and IKK-b (aa 100-300) proteins. Anti-peptide antibodies that specifically recognize p31 comet phosphorylated on residues S4 and T6 were generated in rabbits by the Pacific Immunology Corporation using peptide MAQ-Sp-G-Tp-DLPLRRAH.
Antibodies were used at the following concentrations: antip31 comet (1:1,000, rabbit), anti-IKKb (1:1000, rabbit), antiXenopus cyclin B (1:1,000 rabbit, Abcam), anti-CENP-A (1:1,000 rabbit), anti-Mad1 (1:1,000 rabbit) and anti-GST (1:5,000 mouse, Santa Cruz), anti-xMad2 (1:1,000 rabbit), antiBubR1 (1:1,000 rabbit for western blotting and 1:300 chicken for IF), anti-Cdc20 (1:1,000 rabbit), anti-Spc24 (1:1,000 rabbit), anti-Bub1 (1:1000 rabbit), anti-Aurora B (1:1,000 rabbit), Histone H3 (1:5,000 rabbit, SignalChem), anti-Shugoshin (1:1,000 rabbit), anti-Nup93 (1:1,000 rabbit).
For quantification of Western blots in Figure 1 , 3,5 and 4A films were scanned and ImageJ software was used to quantify respective Western blot bands in the resultant images. For quantification of Western blots in Figure 4C and Figure S5A , images were captured with Gel Logic 6000 Pro system (Carestream) and quantified using Carestream Imaging software.
Kinases (Mps1, Aurora B, IKK-b, Cdk1-Cyclin B) were purchased from SignalChem.
Kinase assays
In Figure 2A , 2 ml of XEEs samples were incubated with 1 mCu [g¡ 32 P]ATP and 2.5 mg GST-p31 comet in a final volume of 25 ml of reaction buffer (40 mM Hepes pH 7.8, 100 mM NaCl, 2 mM MgCl 2 , 40 mM b-glycerolphosphate). Reactions were incubated for 1 hr at 23 C. GST-p31 comet was precipitated on glutathione sepharose beads, and washed 3 times with buffer A (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 0.05% Tween-20, protease inhibitor (EGTA-free tablet, Roche), 0.1 mM Okadic acid, 40 mM b-glycerolphosphate) for 4 times (5 min each). The samples were subjected to SDS-PAGE and 32 P labeled GSTp31 comet was visualized using a phosphoimager and captured by phospho-scanner. GST-p31 comet panel shows the kinase reaction blotted with anti-GST antibodies (third panel).
In Figure 2B , reactions included 500 mM ATP-g-S, 100 ng/ ml GST-p31 comet and 4 ng/ul (of each of each purified kinase, as indicated, in a final volume of 25 ml of reaction buffer (10 mM Tris-Cl pH 7.5, 150 mM NaCl, 10 mM MgCl 2 ). The reactions were incubated for 1 hour at 23 C, and terminated though addition of 20 mM EDTA. 2.5 mM p-nitrobenzyl mesylate (PNBM) was added to each sample, followed by an additional hour of incubation at 23 C. The samples were subjected to SDS-PAGE and Western blotting using the thiophosphate ester specific rabbit (Abcam) antibodies to identify phosphorylated proteins.
Preparation and use of XEEs CSF-XEEs, cycling XEEs and DSN were prepared as described. 27, 14 Unless otherwise indicated, DSN were added at 10,000 DSN/ml, and CaCl 2 was added to a concentration of 0.6 mM to promote mitotic exit of CSF-XEEs. Where indicated, nocodazole was added at 65 mM. Immunodepletions of p31 comet , IKKb and Mad2 were made using antibodies coupled to protein-A Dynal magnetic beads (Life Technologies) through 2 round of depletion. The p31 comet variants were added to depleted XEEs when indicated. In Figure 4C , isolated chromatin was prepared and analyzed as previously described. 27 To assay MCC disruption in Figure 4B , His 6 -tagged p31 comet-wt , p31 comet-AAA or p31 comet-EEE were added at the indicated concentrations to CSF-XEE containing DSN and nocodazole, and incubated at 23 C for 30 min. MCC was immunoprecipitated from each sample using anti-Xenopus Cdc20 antibodies coupled to protein-A Dynal magnetic beads. The beads were washed 3 times with buffer A, eluted with SDS sample buffer and subjected to Western blotting.
In vitro binding of recombinant Mad2 and p31 comet variants In Figure 4A , 100 nM Mad2 and 50 nM His 6 -tagged p31 comet-wt , p31 comet-AAA or p31 comet-EEE were incubated in 1 ml of TBS with 0.05% Tween20 (TBST) buffer at 23 C for 1 hour.
Mad2 was Immunoprecipitated using anti-Mad2 antibodies coupled to Protein A-agarose beads. The beads were washed 3 times using Buffer A and the associated proteins were visualized by SDS-PAGE and CBB staining.
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